Sharma, Abhinav
Weitz, Philippe
Wang, Yinxi
Liu, Bojing
Vallon-Christersson, Johan
Hartman, Johan
Rantalainen, Mattias
Funding for this research was provided by:
Karolinska Institute
Article History
Received: 24 April 2023
Accepted: 15 January 2024
First Online: 29 January 2024
Declarations
:
: The study has approval by the regional ethics review board (Stockholm, Sweden).
: Not applicable.
: JH has obtained speaker's honoraria or advisory board remunerations from Roche, Novartis, AstraZeneca, Eli Lilly and MSD and has received institutional research grants from Cepheid and Novartis. MR and JH are shareholders of Stratipath AB. All other authors have declared no conflicts of interest.